Verastem Valuation
| VSTM Stock | USD 6.10 0.31 4.84% |
At this time, the company appears to be undervalued. Verastem has a current Real Value of $8.58 per share. The regular price of the company is $6.1. Our model measures the value of Verastem from inspecting the company fundamentals such as Return On Equity of -28.89, current valuation of 434.57 M, and Shares Owned By Insiders of 0.87 % as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Verastem's valuation include:
Price Book 15.3454 | Enterprise Value | Enterprise Value Ebitda (0.19) | Price Sales 35.9175 | Enterprise Value Revenue 32.4816 |
Undervalued
Today
Please note that Verastem's price fluctuation is slightly risky at this time. Calculation of the real value of Verastem is based on 3 months time horizon. Increasing Verastem's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Verastem stock is determined by what a typical buyer is willing to pay for full or partial control of Verastem. Since Verastem is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Verastem Stock. However, Verastem's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.1 | Real 8.58 | Target 16.13 | Hype 5.75 | Naive 5.01 |
The intrinsic value of Verastem's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Verastem's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Verastem helps investors to forecast how Verastem stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Verastem more accurately as focusing exclusively on Verastem's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Verastem's intrinsic value based on its ongoing forecasts of Verastem's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Verastem's closest peers.
Verastem Cash |
|
Verastem Revenue by Product
Verastem Total Value Analysis
Verastem is at this time anticipated to have valuation of 434.57 M with market capitalization of 480.54 M, debt of 42.25 M, and cash on hands of 94.31 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Verastem fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
434.57 M | 480.54 M | 42.25 M | 94.31 M |
Verastem Investor Information
About 89.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 4.28. Verastem had not issued any dividends in recent years. The entity had 1:12 split on the 1st of June 2023. Verastem may be sliding down financialy. It has an above-average odds of going through some form of financial crisis next quarter.Verastem Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Verastem has an asset utilization ratio of 9.85 percent. This suggests that the Company is making $0.0985 for each dollar of assets. An increasing asset utilization means that Verastem is more efficient with each dollar of assets it utilizes for everyday operations.Verastem Profitability Analysis
Taking into consideration Verastem's profitability measurements, Verastem's profitability may be sliding down. It has an above-average odds of reporting lower numbers next quarter. Profitability indicators assess Verastem's ability to earn profits and add value for shareholders.Net Loss | First Reported 2011-03-31 | Previous Quarter -25.9 M | Current Value -98.5 M | Quarterly Volatility 16.3 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.89 | 0.71 |
|
|
For Verastem profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Verastem to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Verastem utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Verastem's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Verastem over time as well as its relative position and ranking within its peers.
Verastem Earnings per Share Projection vs Actual
The next projected EPS of Verastem is estimated to be -0.68125 with future projections ranging from a low of -0.75 to a high of -0.6125. Verastem's most recent 12-month trailing earnings per share (EPS TTM) is at -4.28. Please be aware that the consensus of earnings estimates for Verastem is based on EPS before non-recurring items and includes expenses related to employee stock options.Verastem Earnings Estimation Breakdown
The calculation of Verastem's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Verastem is estimated to be -0.68125 with the future projection ranging from a low of -0.75 to a high of -0.6125. Please be aware that this consensus of annual earnings estimates for Verastem is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.75 Lowest | Expected EPS | -0.61 Highest |
Verastem Earnings Projection Consensus
Suppose the current estimates of Verastem's value are higher than the current market price of the Verastem stock. In this case, investors may conclude that Verastem is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Verastem's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2025 | Current EPS (TTM) | |
| 9 | 75.42% | -1.35 | -0.68125 | -4.28 |
Verastem Ownership Allocation
Verastem shows a total of 75.32 Million outstanding shares. The majority of Verastem outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Verastem to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Verastem. Please pay attention to any change in the institutional holdings of Verastem as this could imply that something significant has changed or is about to change at the company. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.Verastem Profitability Analysis
The company reported the previous year's revenue of 10 M. Net Loss for the year was (130.64 M) with profit before overhead, payroll, taxes, and interest of 11.39 M.About Verastem Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of Verastem. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of Verastem based exclusively on its fundamental and basic technical indicators. By analyzing Verastem's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of Verastem's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verastem. We calculate exposure to Verastem's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Verastem's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 11.5 M | 9.2 M | |
| Pretax Profit Margin | (15.00) | (15.75) | |
| Operating Profit Margin | (13.22) | (13.88) | |
| Net Loss | (15.02) | (15.77) | |
| Gross Profit Margin | 0.71 | 0.89 |
Verastem Current Valuation Indicators
Verastem's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final Verastem's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Verastem, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Verastem's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Verastem's worth.When determining whether Verastem is a strong investment it is important to analyze Verastem's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Verastem's future performance. For an informed investment choice regarding Verastem Stock, refer to the following important reports: Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Verastem. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Verastem Stock, please use our How to Invest in Verastem guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Will Biotechnology sector continue expanding? Could Verastem diversify its offerings? Factors like these will boost the valuation of Verastem. If investors know Verastem will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Verastem data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (4.28) | Revenue Per Share | Quarterly Revenue Growth (0.79) | Return On Assets | Return On Equity |
The market value of Verastem is measured differently than its book value, which is the value of Verastem that is recorded on the company's balance sheet. Investors also form their own opinion of Verastem's value that differs from its market value or its book value, called intrinsic value, which is Verastem's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Verastem's market value can be influenced by many factors that don't directly affect Verastem's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Verastem's value and its price as these two are different measures arrived at by different means. Investors typically determine if Verastem is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Verastem's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.